| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF142 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | TGS1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | MAD2L1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | RFXAP | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | R3HDM1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | SLC2A10 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-08 |
| mRNA | NCL | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | RCOR2 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | RMND5A | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | EPS8L2 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-08 |
